Page last updated: 2024-10-23

benzyl isothiocyanate and Carcinoma, Papillary

benzyl isothiocyanate has been researched along with Carcinoma, Papillary in 1 studies

benzyl isothiocyanate: inhibits carcinogen-induced neoplasia; structure in Negwer, 5th ed, #715; also promotes urinary bladder carcinoma

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Okazaki, K1
Umemura, T1
Imazawa, T1
Nishikawa, A1
Masegi, T1
Hirose, M1

Other Studies

1 other study available for benzyl isothiocyanate and Carcinoma, Papillary

ArticleYear
Enhancement of urinary bladder carcinogenesis by combined treatment with benzyl isothiocyanate and N-butyl-N-(4-hydroxybutyl)nitrosamine in rats after initiation.
    Cancer science, 2003, Volume: 94, Issue:11

    Topics: Animals; Butylhydroxybutylnitrosamine; Carcinoma, Papillary; Drug Combinations; Hyperplasia; Isothio

2003